Sort
8,912 grants matching “sars cov 2”
1/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
$126,761Sean Cl Deoni · Rhode Island Hospital · R34 · FY2020 · DA
Comparative, single-cell analysis of COVID-19 and other respiratory diseases
$126,750Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · HL
Comparative, single-cell analysis of COVID-19 and other respiratory diseases
$126,750Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · HL
JH-EPICS Administrative Core
$126,659Sabra L Klein · Johns Hopkins University · U54 · FY2024 · CA
Virology Resource Core
$126,658Andrew S. Pekosz · Johns Hopkins University · U54 · FY2024 · CA
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
$126,657Sabra L Klein · Johns Hopkins University · U54 · FY2024 · CA
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$126,657Jonathan D Powell · Johns Hopkins University · U54 · FY2024 · CA
Analysis Resource Core
$126,657Scott L. Zeger · Johns Hopkins University · U54 · FY2024 · CA
Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2
$126,657Andrea L Cox · Johns Hopkins University · U54 · FY2024 · CA
COVID-19 transmission in Alaska: geographic and genomic modeling
$126,175Brian M Barnes · University Of Alaska Fairbanks · P20 · FY2022 · GM
Clinical Core
$126,110Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2025 · AI
Effect of Covid-19 on chronic kidney disease progression
$126,000Meghan E. Sise · Massachusetts General Hospital · R03 · FY2022 · DK
Effect of Covid-19 on chronic kidney disease progression
$126,000Meghan E. Sise · Massachusetts General Hospital · R03 · FY2021 · DK
Human Immune Monitoring Core
$125,920Holden T. Maecker · Stanford University · U19 · FY2024 · AI
Antibody discovery
$125,849Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Assessment of Zoonotic Risk of Emerging Infections in Companion Animals
$125,600Laura Brunengraber Goodman · Cornell University · U18 · FY2020 · FD
Scientific Project 3: Covid Immune response to SARS-CoV-2 natural infection followed by vaccination
$125,294Gregory Lee Szeto · Seattle Children'S Hospital · U19 · FY2024 · AI
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
$125,031Robert Pickett Dickson · University Of Michigan At Ann Arbor · K24 · FY2024 · HL
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
$125,031Robert Pickett Dickson · University Of Michigan At Ann Arbor · K24 · FY2022 · HL
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
$125,031Robert Pickett Dickson · University Of Michigan At Ann Arbor · K24 · FY2023 · HL
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
$125,031Robert Pickett Dickson · University Of Michigan At Ann Arbor · K24 · FY2025 · HL
Decoding Viral Control of Host Kinase Signaling to Design Combination Therapy
$125,010Mehdi Bouhaddou · University Of California, San Francisco · K99 · FY2022 · AI
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
$125,000Argentina Elisa Noelle Servin · University Of California, San Diego · R01 · FY2023 · MD
Bridging Disparate Structural/Functional Scales: Multiscale Modeling of Genome Organization and if Viral RNA Frameshifting
$125,000Tamar Schlick · New York University · R35 · FY2024 · GM
RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES -TASK ORDER 06
$125,000Rebekah Anne Neal · Venturewell · N02 · FY2024 · EB